These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22951216)

  • 41. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F; Persijn L; Decavele AS; Devreese K
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiphospholipid antibodies, antiphospholipid syndrome and infections.
    Sène D; Piette JC; Cacoub P
    Autoimmun Rev; 2008 Feb; 7(4):272-7. PubMed ID: 18295729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study.
    Su Z; Huang Z; Zhao J; Li M; Hu J; Zeng X; Hu C; Yang B
    Clin Appl Thromb Hemost; 2022; 28():10760296221081129. PubMed ID: 35379020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Standardization of antiphospholipid antibody testing--historical perspectives and ongoing initiatives.
    Willis R; Lakos G; Harris EN
    Semin Thromb Hemost; 2014 Mar; 40(2):172-7. PubMed ID: 24470286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-beta2-glycoprotein I antibodies.
    Tsutsumi A; Ichikawa K; Matsuura E; Koike T
    Lupus; 1998; 7 Suppl 2():S98-102. PubMed ID: 9814683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.
    Ferrer-Oliveras R; Llurba E; Cabero-Roura L; Alijotas-Reig J
    Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.
    Janek D; Slavik L; Ulehlova J; Krcova V; Hlusi A; Prochazkova J
    Clin Lab; 2016 Jul; 62(7):1309-1315. PubMed ID: 28164648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease.
    Palomo I; Segovia F; Ortega C; Pierangeli S
    Clin Exp Rheumatol; 2009; 27(4):668-77. PubMed ID: 19772805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients.
    Kumar S; Papalardo E; Sunkureddi P; Najam S; González EB; Pierangeli SS
    Lupus; 2009 Oct; 18(11):1011-4. PubMed ID: 19762404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.